Fady Ibraham Malik, EVP Research & Development at CYTOKINETICS INC (CYTK), sold 4,590 shares at $59.55 ($273K) on 2025-11-04, disclosed to the SEC on 2025-11-04.
Scheduled sale ($273k) by EVP Research & Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.55 | 2,295 | $137K | 50.0% |
| 2 | $59.55 | 2,295 | $137K | 50.0% |
| Total | $59.55 avg | 4,590 | $273K | 100% |
| Filing → |
| CYTK | SELL | 2026-08-18 | $265K | — | Filing → |
| CYTK | SELL | 2026-07-23 | $282K | — | Filing → |
| CYTK | SELL | 2026-07-07 | $303K | — | Filing → |